chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 20.0
Sex: M
Vaccine: SMALL
Symptoms: Incorrect drug dosage form administered
Clinical narrative: Patient recieved smallpox vaccine that was reconstituted with sterile water instead of 50% glycerin, and 0.25% phenol in Sterile Water. Patient does not have any adverse reaction site looks within normal limits.
Age: 16.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Erythema, Pruritus, Rash, Rash papular, Skin exfoliation
Clinical narrative: Patient received MCV4 in Left deltoid and Tdap  in Right deltoid on 5/12/09. She came in 5/18/09 c/o left upper arm itching for a few days (approx started 5/15/09). Noted reddness & bumps on 5/18/09 so came into clinic to be checked. On exam of Left upper arm, found erythemam, increased warmth and flesh colored papules below injection site. Also had scaly white mark where bandaid had been. Right arm unremarkable. Applied small amount OTC hydrocortisone cream to area and ice pack applied.  Patient returned later in day and said itching had resolved. On exam reddness and warmth had resolved. told to watch and monitor and return if symptoms return.
Age: 16.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Skin warm
Clinical narrative: Patient received MCV4 in Left deltoid and Tdap  in Right deltoid on 5/12/09. She came in 5/18/09 c/o left upper arm itching for a few days (approx started 5/15/09). Noted reddness & bumps on 5/18/09 so came into clinic to be checked. On exam of Left upper arm, found erythemam, increased warmth and flesh colored papules below injection site. Also had scaly white mark where bandaid had been. Right arm unremarkable. Applied small amount OTC hydrocortisone cream to area and ice pack applied.  Patient returned later in day and said itching had resolved. On exam reddness and warmth had resolved. told to watch and monitor and return if symptoms return.
Age: 26.0
Sex: M
Vaccine: SMALL, YF
Symptoms: Incorrect drug dosage form administered
Clinical narrative: Patient recieved smallpox vaccine that was reconstituted with sterile water instead of 50% glycerin, and 0.25% phenol in Sterile Water. Patient does not have any adverse reaction site looks within normal limits.
Age: 0.33
Sex: F
Vaccine: RV5
Symptoms: Abdominal pain upper, Cranial nerve disorder, Crying, Diarrhoea, Discomfort
Clinical narrative: Adverse side effects include: diarrhea, stomach pain, discomfort, cranky behavior, problems with sleep, excessive crying, but no fever. The adverse effects came next day after administration of the second dose of Rotateq vaccine. The first dose of Rotateq gave no adverse effects. Rotateq was the only vaccine given to the child. The child was not sick, no fever, no teething. The adverse effects were present for one day.
Age: 0.33
Sex: F
Vaccine: RV5
Symptoms: Insomnia, Irritability, No reaction on previous exposure to drug
Clinical narrative: Adverse side effects include: diarrhea, stomach pain, discomfort, cranky behavior, problems with sleep, excessive crying, but no fever. The adverse effects came next day after administration of the second dose of Rotateq vaccine. The first dose of Rotateq gave no adverse effects. Rotateq was the only vaccine given to the child. The child was not sick, no fever, no teething. The adverse effects were present for one day.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Incorrect drug dosage form administered
Clinical narrative: Patient recieved smallpox vaccine that was reconstituted with sterile water instead of 50% glycerin, and 0.25% phenol in Sterile Water. Patient does not have any adverse reaction site looks within normal limits.
Age: 26.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Incorrect drug dosage form administered
Clinical narrative: Patient recieved smallpox vaccine that was reconstituted with sterile water instead of 50% glycerin, and 0.25% phenol in Sterile Water. Patient does not have any adverse reaction site looks within normal limits.
Age: 16.0
Sex: F
Vaccine: HPV4, TDAP, VARCEL
Symptoms: Erythema, Nodule, Pyrexia, Swelling
Clinical narrative: Patient had baseball size knot with redness, swelling and fever noted. Pt taking benadryl.
Age: 19.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Incorrect drug dosage form administered
Clinical narrative: Patient recieved smallpox vaccine that was reconstituted with sterile water instead of 50% glycerin, and 0.25% phenol in Sterile Water. Patient does not have any adverse reaction site looks within normal limits.
Age: 62.0
Sex: F
Vaccine: HEP, HEPA
Symptoms: Expired drug administered
Clinical narrative: Accidently administered an expired Hep A vaccine to patient. She did not have any adverse symptoms at the time.  No treatment given.
Age: 19.0
Sex: F
Vaccine: ANTH, SMALL, TYP
Symptoms: Incorrect drug dosage form administered
Clinical narrative: Patient recieved smallpox vaccine that was reconstituted with sterile water instead of 50% glycerin, and 0.25% phenol in Sterile Water. Patient does not have any adverse reaction site looks within normal limits.
Age: 11.0
Sex: F
Vaccine: HPV4
Symptoms: Ataxia, Computerised tomogram normal, Dizziness, Full blood count normal, Headache
Clinical narrative: 3 [[name]]s after second gardasil, pt went to ER for dizziness, ataxia and severe headache[[address]]head and lab work all negative.  7/2/09 Received ER medical records of 4/22/2008. FINAL DX: Records reveal patient experienced dizziness, ataxia, nausea, HA x 1 [[name]].  Tx w/antivert & d/c to home w/PCP f/u.  5/21/09 Received PCP office record of 4/23/08 s/p ER visit [[name]] before for HA & dizziness.  ENT & Neuro exams WNL.  Dx w/HA.
Age: 11.0
Sex: F
Vaccine: HPV4
Symptoms: Urine analysis normal
Clinical narrative: 3 [[name]]s after second gardasil, pt went to ER for dizziness, ataxia and severe headache[[address]]head and lab work all negative.  7/2/09 Received ER medical records of 4/22/2008. FINAL DX: Records reveal patient experienced dizziness, ataxia, nausea, HA x 1 [[name]].  Tx w/antivert & d/c to home w/PCP f/u.  5/21/09 Received PCP office record of 4/23/08 s/p ER visit [[name]] before for HA & dizziness.  ENT & Neuro exams WNL.  Dx w/HA.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Erythema, Oedema peripheral, Pain in extremity
Clinical narrative: Pt. brought immigration form from civil surgeon with need for Td, PPV, Varicella (due to neg blood titer) and Zoster. I said Zostavax not needed because was neg for chickenpox.  Returned 5/18 with pain & erythema in left forearm. Said she had Zostavax at a pharmacy (against my advice) on 5/13. Pain, swelling & erythema began 5/17. Referred to Clinic for MD assessment due to pain.  MD called to HD & unsure but felt it may be Zoster from vaccine and put on an anti-viral medication.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Erythema, Oedema peripheral, Pain in extremity, Skin warm
Clinical narrative: Pt. brought immigration form from civil surgeon with need for Td, PPV, Varicella (due to neg blood titer) and Zoster. I said Zostavax not needed because was neg for chickenpox.  Returned 5/18 with pain & erythema in left forearm. Said she had Zostavax at a pharmacy (against my advice) on 5/13. Pain, swelling & erythema began 5/17. Referred to Clinic for MD assessment due to pain.  MD called to HD & unsure but felt it may be Zoster from vaccine and put on an anti-viral medication.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Erythema, Pain, Rash vesicular
Clinical narrative: Pt. brought immigration form from civil surgeon with need for Td, PPV, Varicella (due to neg blood titer) and Zoster. I said Zostavax not needed because was neg for chickenpox.  Returned 5/18 with pain & erythema in left forearm. Said she had Zostavax at a pharmacy (against my advice) on 5/13. Pain, swelling & erythema began 5/17. Referred to Clinic for MD assessment due to pain.  MD called to HD & unsure but felt it may be Zoster from vaccine and put on an anti-viral medication.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Erythema, Oedema peripheral, Pain in extremity
Clinical narrative: Pain, erythema, vesicular rash in dermatome distribution (L/arm). Rx : ACYCLOVIR 800 5x/d. LYRICA 50. tid and VICODIN.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Erythema, Oedema peripheral, Pain in extremity, Skin warm
Clinical narrative: Pain, erythema, vesicular rash in dermatome distribution (L/arm). Rx : ACYCLOVIR 800 5x/d. LYRICA 50. tid and VICODIN.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Erythema, Pain, Rash vesicular
Clinical narrative: Pain, erythema, vesicular rash in dermatome distribution (L/arm). Rx : ACYCLOVIR 800 5x/d. LYRICA 50. tid and VICODIN.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Incorrect drug dosage form administered
Clinical narrative: Patient recieved smallpox vaccine that was reconstituted with sterile water instead of 50% glycerin, and 0.25% phenol in Sterile Water. Patient does not have any adverse reaction site looks within normal limits.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Incorrect drug dosage form administered
Clinical narrative: Patient recieved smallpox vaccine that was reconstituted with sterile water instead of 50% glycerin, and 0.25% phenol in Sterile Water. Patient does not have any adverse reaction site looks within normal limits.
Age: 23.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Incorrect drug dosage form administered
Clinical narrative: Patient recieved smallpox vaccine that was reconstituted with sterile water instead of 50% glycerin, and 0.25% phenol in Sterile Water. Patient does not have any adverse reaction site looks within normal limits.
Age: 41.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Blood creatinine normal, Blood urea normal, Erythema, Induration, Oedema peripheral
Clinical narrative: 5 days after receiving vaccines, he had left upper extremity swelling, redness, and warmth. His left thumb base was itching. There was left thumb pain with motion. Today, he noted right 4th finger tip being hard.  6/2/09 ED and inpatient hospital records received DOS 5/19/09 to 5/21/09. FINAL DIAGNOSIS: Hypertension, hand cellulitis. Post vaccination presented with swelling in left arm, erythema. Itching and bruising of left thumb, painful on motion, pain at base of thumb. Erythema, swelling, and purplish discoloration of right middle finger. Pain and swelling of left knee. Purulent area, with erythema at site of smallpox vaccine on right biceps. Infectious disease consult notes whitish pustule on right arm.  ICD-9 Codes: 682.4 Cellulitis/Abcess Hand Exc Finger/Thumb, 401.9 Hypertension NOS.
Age: 41.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Pain in extremity, Pruritus, Skin warm, Ultrasound scan abnormal, White blood cell count increased
Clinical narrative: 5 days after receiving vaccines, he had left upper extremity swelling, redness, and warmth. His left thumb base was itching. There was left thumb pain with motion. Today, he noted right 4th finger tip being hard.  6/2/09 ED and inpatient hospital records received DOS 5/19/09 to 5/21/09. FINAL DIAGNOSIS: Hypertension, hand cellulitis. Post vaccination presented with swelling in left arm, erythema. Itching and bruising of left thumb, painful on motion, pain at base of thumb. Erythema, swelling, and purplish discoloration of right middle finger. Pain and swelling of left knee. Purulent area, with erythema at site of smallpox vaccine on right biceps. Infectious disease consult notes whitish pustule on right arm.  ICD-9 Codes: 682.4 Cellulitis/Abcess Hand Exc Finger/Thumb, 401.9 Hypertension NOS.
Age: 41.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Arthralgia, Blood creatinine normal, Blood urea normal, Cellulitis, Erythema
Clinical narrative: 5 days after receiving vaccines, he had left upper extremity swelling, redness, and warmth. His left thumb base was itching. There was left thumb pain with motion. Today, he noted right 4th finger tip being hard.  6/2/09 ED and inpatient hospital records received DOS 5/19/09 to 5/21/09. FINAL DIAGNOSIS: Hypertension, hand cellulitis. Post vaccination presented with swelling in left arm, erythema. Itching and bruising of left thumb, painful on motion, pain at base of thumb. Erythema, swelling, and purplish discoloration of right middle finger. Pain and swelling of left knee. Purulent area, with erythema at site of smallpox vaccine on right biceps. Infectious disease consult notes whitish pustule on right arm.  ICD-9 Codes: 682.4 Cellulitis/Abcess Hand Exc Finger/Thumb, 401.9 Hypertension NOS.
Age: 41.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Hypertension, Induration, Injection site erythema, Injection site pruritus, Joint swelling
Clinical narrative: 5 days after receiving vaccines, he had left upper extremity swelling, redness, and warmth. His left thumb base was itching. There was left thumb pain with motion. Today, he noted right 4th finger tip being hard.  6/2/09 ED and inpatient hospital records received DOS 5/19/09 to 5/21/09. FINAL DIAGNOSIS: Hypertension, hand cellulitis. Post vaccination presented with swelling in left arm, erythema. Itching and bruising of left thumb, painful on motion, pain at base of thumb. Erythema, swelling, and purplish discoloration of right middle finger. Pain and swelling of left knee. Purulent area, with erythema at site of smallpox vaccine on right biceps. Infectious disease consult notes whitish pustule on right arm.  ICD-9 Codes: 682.4 Cellulitis/Abcess Hand Exc Finger/Thumb, 401.9 Hypertension NOS.
Age: 41.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Oedema peripheral, Pain, Pain in extremity, Pruritus, Rash pustular
Clinical narrative: 5 days after receiving vaccines, he had left upper extremity swelling, redness, and warmth. His left thumb base was itching. There was left thumb pain with motion. Today, he noted right 4th finger tip being hard.  6/2/09 ED and inpatient hospital records received DOS 5/19/09 to 5/21/09. FINAL DIAGNOSIS: Hypertension, hand cellulitis. Post vaccination presented with swelling in left arm, erythema. Itching and bruising of left thumb, painful on motion, pain at base of thumb. Erythema, swelling, and purplish discoloration of right middle finger. Pain and swelling of left knee. Purulent area, with erythema at site of smallpox vaccine on right biceps. Infectious disease consult notes whitish pustule on right arm.  ICD-9 Codes: 682.4 Cellulitis/Abcess Hand Exc Finger/Thumb, 401.9 Hypertension NOS.
Age: 41.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Skin discolouration, Skin warm, Ultrasound scan abnormal, White blood cell count increased
Clinical narrative: 5 days after receiving vaccines, he had left upper extremity swelling, redness, and warmth. His left thumb base was itching. There was left thumb pain with motion. Today, he noted right 4th finger tip being hard.  6/2/09 ED and inpatient hospital records received DOS 5/19/09 to 5/21/09. FINAL DIAGNOSIS: Hypertension, hand cellulitis. Post vaccination presented with swelling in left arm, erythema. Itching and bruising of left thumb, painful on motion, pain at base of thumb. Erythema, swelling, and purplish discoloration of right middle finger. Pain and swelling of left knee. Purulent area, with erythema at site of smallpox vaccine on right biceps. Infectious disease consult notes whitish pustule on right arm.  ICD-9 Codes: 682.4 Cellulitis/Abcess Hand Exc Finger/Thumb, 401.9 Hypertension NOS.
Age: 28.0
Sex: M
Vaccine: HEP, TD
Symptoms: Anorexia, Asthenia, Dizziness, Fall, Head injury
Clinical narrative: First a feeling of nausia.  Sycope within minutes of the injections.  Fell and hit head.  Regained consciousness within a few minutes under care of the doctor.  Slightly light headed and weak the rest of the day.  Loss of appetite.
Age: 28.0
Sex: M
Vaccine: HEP, TD
Symptoms: Nausea, Syncope
Clinical narrative: First a feeling of nausia.  Sycope within minutes of the injections.  Fell and hit head.  Regained consciousness within a few minutes under care of the doctor.  Slightly light headed and weak the rest of the day.  Loss of appetite.
Age: 4.0
Sex: M
Vaccine: DTAP, HEP, VARCEL
Symptoms: Vomiting
Clinical narrative: PT COM[PLAINING OF VOMITING AFTER VACCINES WERE ADMINISTERED. HE WAS SEEN BY ANOTHER PROVIDER LATER THE SAME EVENING.
Age: 29.0
Sex: F
Vaccine: DTAP
Symptoms: Injected limb mobility decreased, Lymph gland infection, Lymph node pain, Lymphadenopathy, Musculoskeletal stiffness
Clinical narrative: Extreme pain in arm of injection, inability to move/lift arm, extreme stiffness and pain in neck, enlarged and painful/tender touch glands in neck. Could feel several lumps under skin - swollen and infected glands
Age: 29.0
Sex: F
Vaccine: DTAP
Symptoms: Neck pain, Pain in extremity
Clinical narrative: Extreme pain in arm of injection, inability to move/lift arm, extreme stiffness and pain in neck, enlarged and painful/tender touch glands in neck. Could feel several lumps under skin - swollen and infected glands
Age: 0.2
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Heart rate increased, Immediate post-injection reaction, Lethargy, Oxygen saturation normal, Pallor
Clinical narrative: Immediately post immunizations baby became very pale & lethargic HR 100 initially - increased 120s with stimuli pulse 0 X 96 arousable but sleepy good tone.  Baby observed.
Age: 0.2
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Somnolence
Clinical narrative: Immediately post immunizations baby became very pale & lethargic HR 100 initially - increased 120s with stimuli pulse 0 X 96 arousable but sleepy good tone.  Baby observed.
Age: 1.2
Sex: M
Vaccine: DTAP, HIBV, MMR
Symptoms: Urticaria
Clinical narrative: Patient returned 30 min after immunization with hives.  Lungs CTA Heart Reg Benadryl 12.5mg given- pt observed x 20 min still with hives but active.
Age: 4.0
Sex: F
Vaccine: DTAPHEPBIP, MMR, VARCEL
Symptoms: Injection site erythema, Injection site warmth, Local reaction
Clinical narrative: Localized warmth, erythema approx 10 cm around injection site.
Age: 18.0
Sex: M
Vaccine: HEPA
Symptoms: No adverse event
Clinical narrative: No adverse effects noted per patients father - 5-13-09.
Age: 14.0
Sex: M
Vaccine: DTAP, HEPA, TYP
Symptoms: Injection site pain
Clinical narrative: His father stated that his "arm is sore."  No other adverse effects noted, 5-13-09.
Age: 11.0
Sex: F
Vaccine: HEPA, HPV4, TDAP
Symptoms: Oedema peripheral, Paraesthesia
Clinical narrative: IM injections were given at 2:30 pm; Pt waited in the room for 15 minutes.  Waiting then to have lab drawn noticed her right hand swelling on the dorsal surface over the 2nd & 3rd metacarpals and tingling of her 2nd & 3rd fingers; normal movement, grip, and pulses; A dose of ALLEGRA 180 mg was given; After 30 minutes her symptoms were improving, less tingling, less swelling; Pt went home
Sex: U
Vaccine: RV1
Symptoms: Acidosis, Blood bicarbonate decreased, Diarrhoea haemorrhagic
Clinical narrative: This case was reported by a physician via a GSK representative, and described the occurrence of bloody diarrhea in a subject of unspecified age and gender who was vaccinated with ROTARIX (GlaxoSmithKline). The subject's medical history included cow milk protein allergy. On an unspecified date the subject received 1st dose of ROTARIX (1 ml, oral). At an unspecified time after vaccination with ROTARIX, the subject experienced bloody diarrhea. The subject also experienced decreased bicarbonate (11-12, unspecified units) and acidosis after a least one dose of ROTARIX. It was unclear whether the subject experienced decreased bicarbonate and acidosis after the 1st dose, 2nd dose or both doses. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the events was unspecified. After the next vaccination with ROTARIX the events recurred (see case A0784664B for more details). There was no further information at the time of reporting.
Sex: U
Vaccine: RV1
Symptoms: Acidosis, Blood bicarbonate decreased, Diarrhoea haemorrhagic, Vaccine positive rechallenge
Clinical narrative: This case was reported by a physician via a GSK representative, and described the occurrence of bloody diarrhea in a subject of unspecified age and gender who was vaccinated with ROTARIX (GlaxoSmithKline). The subject's medical history included bloody diarrhea and cow milk protein allergy. The subject had experienced bloody diarrhea and possibly decreased bicarbonate and acidosis after the 1st dose of ROTARIX (see case A0784664A for more details). On an unspecified date the subject received 2nd dose of ROTARIX (1 ml, oral). At an unspecified time after vaccination with ROTARIX, the subject experienced bloody diarrhea. The subject also experienced decreased bicarbonate (11-12, unspecified units) and acidosis after a least one dose of ROTARIX. It was unclear whether the subject experienced decreased bicarbonate and acidosis after the 1st dose, 2nd dose or both doses. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the events was unspecified. There was no further information at the time of reporting.
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, HPV4, MEN, TD, HPV4, MNQ, TDAP
Symptoms: Arthralgia, Blood creatine phosphokinase normal, Chest discomfort, Feeling hot, Full blood count normal
Clinical narrative: C/o pain in muscles, joints.  Felt hot all over, pressure in chest.  Given IV fluids DILAUDID, ZOFRAN in ER.  5/6/09 6 am D/C with VICODIN for pain.
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, HPV4, MEN, TD, HPV4, MNQ, TDAP
Symptoms: Influenza serology negative, Myalgia, Urine analysis normal
Clinical narrative: C/o pain in muscles, joints.  Felt hot all over, pressure in chest.  Given IV fluids DILAUDID, ZOFRAN in ER.  5/6/09 6 am D/C with VICODIN for pain.
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, HPV4, MEN, TD, HPV4, MNQ, TDAP
Symptoms: Abdominal pain, Chest pain, Nausea, Pain in extremity, Pyrexia
Clinical narrative: C/o pain in muscles, joints.  Felt hot all over, pressure in chest.  Given IV fluids DILAUDID, ZOFRAN in ER.  5/6/09 6 am D/C with VICODIN for pain.
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, HPV4, MEN, TD, HPV4, MNQ, TDAP
Symptoms: Urine analysis normal
Clinical narrative: C/o pain in muscles, joints.  Felt hot all over, pressure in chest.  Given IV fluids DILAUDID, ZOFRAN in ER.  5/6/09 6 am D/C with VICODIN for pain.
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, HPV4, MEN, TD, HPV4, MNQ, TDAP
Symptoms: Abdominal pain, Blood creatine phosphokinase abnormal, Chest pain, Chills, Chromaturia
Clinical narrative: C/o pain in muscles, joints.  Felt hot all over, pressure in chest.  Given IV fluids DILAUDID, ZOFRAN in ER.  5/6/09 6 am D/C with VICODIN for pain.
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, HPV4, MEN, TD, HPV4, MNQ, TDAP
Symptoms: Cough, Feeling hot, Full blood count, Laboratory test normal, Metabolic function test
Clinical narrative: C/o pain in muscles, joints.  Felt hot all over, pressure in chest.  Given IV fluids DILAUDID, ZOFRAN in ER.  5/6/09 6 am D/C with VICODIN for pain.
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, HPV4, MEN, TD, HPV4, MNQ, TDAP
Symptoms: Nausea, Pain, Pain in extremity, Pain of skin, Tremor
Clinical narrative: C/o pain in muscles, joints.  Felt hot all over, pressure in chest.  Given IV fluids DILAUDID, ZOFRAN in ER.  5/6/09 6 am D/C with VICODIN for pain.
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, HPV4, MEN, TD, HPV4, MNQ, TDAP
Symptoms: Urine analysis
Clinical narrative: C/o pain in muscles, joints.  Felt hot all over, pressure in chest.  Given IV fluids DILAUDID, ZOFRAN in ER.  5/6/09 6 am D/C with VICODIN for pain.
Age: 0.5
Sex: F
Vaccine: DTAPIPVHIB, PNC, RV5
Symptoms: Pyrexia
Clinical narrative: Fever 102.5 within 24 hrs of vaccine administration.
Age: 42.0
Sex: F
Vaccine: HEPAB
Symptoms: Back pain, Pain, Restlessness, Sleep disorder
Clinical narrative: Severe back ache in mid + lower back muscles which woke me from sleep.  Restlessness + achey that night.  Gradually decreased over next 3 days.
Age: 9.0
Sex: F
Vaccine: HPV4
Symptoms: Asthenia, Chills, Dizziness, Ear pain, Eye pain
Clinical narrative: - Pain & bruised at injection site - high fever - Paleness, Weak, dizzy - Sore throat, ear ache, sore eyes - chills 3 days MOTRIN & TYLENOT given
Age: 9.0
Sex: F
Vaccine: HPV4
Symptoms: Injection site haematoma, Injection site pain, Oropharyngeal pain, Pallor, Pyrexia
Clinical narrative: - Pain & bruised at injection site - high fever - Paleness, Weak, dizzy - Sore throat, ear ache, sore eyes - chills 3 days MOTRIN & TYLENOT given
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Noticed L upper pain with 3" swelling, redness, heat, hardness.  5-12-09 Went to place @ 6-7 pm.-  was told "reaction to tetanus but not bad enough not to have tetanus in future."  They advised Benadryl 5-13-09 9am mom called office to report- less swelling redness less pain today.
Age: 10.0
Sex: F
Vaccine: TDAP
Symptoms: Cellulitis, Erythema, Injection site cellulitis, Pain in extremity, Skin warm
Clinical narrative: Redness, swelling, 6" down arm, 3-4" wide, with heat.  No fever.  Pain in arm as well.  Diagnosis cellulitis secondary to injection.  Tx with AUGMENTIN 500 mg po BID x 10 days
Age: 10.0
Sex: F
Vaccine: TDAP
Symptoms: Swelling
Clinical narrative: Redness, swelling, 6" down arm, 3-4" wide, with heat.  No fever.  Pain in arm as well.  Diagnosis cellulitis secondary to injection.  Tx with AUGMENTIN 500 mg po BID x 10 days
Age: 1.1
Sex: F
Vaccine: MMR, PNC, VARCEL
Symptoms: Cough, Lethargy, Pyrexia, Rash, Rhinorrhoea
Clinical narrative: Fever, lethargy, rash started 6 days following vaccination.  Some rhinorrhea started 5/8/09 with slight cough  Fever > 104 degrees.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Oral herpes
Clinical narrative: Fever blisters branching out / popping up on nose area - 7 total so far, patient was contacting doctor.
Age: 41.0
Sex: M
Vaccine: HEPA
Symptoms: Dry skin, Pruritus, Rash
Clinical narrative: Pt. developed rash behind his leg, forearms and few spots on trunk.  Describes as itchy, appears dry, Flat.  Began approx.  24 hours post 2nd dose HEP A vaccine.  Pt. had sunburned skin on same areas prior to vaccine and rash
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Borrelia burgdorferi serology negative, Facial palsy
Clinical narrative: Bell's palsy - few hrs. after Gardasil #3.
Age: 43.0
Sex: M
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Arm swollen and red at injection site.
Age: 1.7
Sex: F
Vaccine: DTAPIPV, MMR
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: KINRIX prepared for older sister & accidently given to younger child.
Age: 36.0
Sex: F
Vaccine: RAB
Symptoms: Anticonvulsant drug level therapeutic, Convulsion, Dizziness, Headache, Lymphadenopathy
Clinical narrative: HA, dizziness, malaise, swelling of lymph nodes day of injection.  Involuntary muscle twitching seizure on Saturday.
Age: 36.0
Sex: F
Vaccine: RAB
Symptoms: Malaise, Muscle twitching
Clinical narrative: HA, dizziness, malaise, swelling of lymph nodes day of injection.  Involuntary muscle twitching seizure on Saturday.
Age: 17.0
Sex: F
Vaccine: HEPA, HPV4
Symptoms: Feeling abnormal, Sensation of heaviness, Syncope, Tremor
Clinical narrative: Patient received Hep A on right arm and HPV on Left arm a few seconds later while nurse in room had dazed look and feeling a heavy feeling lay back some shaking + fainted nurse put her feet up she woke up and said she had a weird feeling + no treatment walked out of clinic given water felt better.
Age: 15.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Blood glucose increased, Crying, Dyskinesia, Hypotonia, Unresponsive to stimuli
Clinical narrative: Pt received Tdap, HPV and Menactra and then slumped over into mother's arms motionless, then jerked involuntarily and was layed down with eyes open & unresponsive.  About 10 sec. later pt. jerked again and sat up crying and wanting to know what was happening.  Pt was kept approx. 20 min.  VS stable and accucheck done- 131.  Was allowed to leave after taking po fluids.
Age: 2.0
Sex: M
Vaccine: DTAP, HEPA
Symptoms: Fatigue, Injection site pain, Injection site rash, Injection site swelling, Injection site warmth
Clinical narrative: Patient was fatigued a few hours after the injection.  About 6 hrs after injections, there was a small rash around area.  Fever started @ 10:pm, patient c/o his leg hurt.  Injection site next day hot, swollen and painful.
Age: 2.0
Sex: M
Vaccine: DTAP, HEPA
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Patient was fatigued a few hours after the injection.  About 6 hrs after injections, there was a small rash around area.  Fever started @ 10:pm, patient c/o his leg hurt.  Injection site next day hot, swollen and painful.
Age: 62.0
Sex: M
Vaccine: TDAP
Symptoms: Back pain, Oedema peripheral, Pain in extremity, Pyrexia
Clinical narrative: Fever, arm swelling, leg and back - pain.
Age: 14.0
Sex: F
Vaccine: TDAP, VARCEL, TDAP, VARCEL
Symptoms: Dizziness, Fatigue, Heart rate increased, Nausea, Pain in extremity
Clinical narrative: Nausea, dizziness, pulse rate 100, low grade fever, sore arm w/hot to touch + tired.  These symptoms started about 12  hrs after vaccine was given and she felt the worst 36-48 hrs later.  She still feels tired + a little dizzy.
Age: 14.0
Sex: F
Vaccine: TDAP, VARCEL, TDAP, VARCEL
Symptoms: Pyrexia, Skin warm
Clinical narrative: Nausea, dizziness, pulse rate 100, low grade fever, sore arm w/hot to touch + tired.  These symptoms started about 12  hrs after vaccine was given and she felt the worst 36-48 hrs later.  She still feels tired + a little dizzy.
Age: 14.0
Sex: F
Vaccine: TDAP, VARCEL, TDAP, VARCEL
Symptoms: Dizziness, Heart rate increased, Nausea, Pain in extremity
Clinical narrative: Nausea, dizziness, pulse rate 100, low grade fever, sore arm w/hot to touch + tired.  These symptoms started about 12  hrs after vaccine was given and she felt the worst 36-48 hrs later.  She still feels tired + a little dizzy.
Age: 16.0
Sex: F
Vaccine: HEPA, MNQ, TDAP
Symptoms: Fall, Loss of consciousness, Syncope
Clinical narrative: Patient fainted about 10 minutes after the last shot, falling off the table. ? L.O.C for about 3 minutes.
Age: 0.3
Sex: F
Vaccine: DTAP, HIBV, IPV
Symptoms: Crying, Irritability
Clinical narrative: Crying alot.  Extreme fussiness trouble sleeping.   only when carried.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site vesicles, Injection site warmth
Clinical narrative: Red, swollen, warm, painful area to upper right thigh 24 hours post vaccination.  Approx 24 cm X 19cm.  Also noted several fluid - filled vesicles at injection site.  24 cm X 19 cm
Age: 1.2
Sex: F
Vaccine: DTAP, PNC
Symptoms: Lethargy, Pyrexia, Urticaria
Clinical narrative: Patient had high fever to 104 with lethargy on day of vaccinations, after they were given. 2 days later she developed hives that lasted for 2-3 days. Patient had full recovery.
Age: 68.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Chills, Injection site erythema, Injection site induration, Injection site pain, Injection site rash
Clinical narrative: 5/4/09 ZOSTAVAX administered; pain at injection site 5/5/09 redness/hardness 3 inches wide & 6 inches long extending from injection site & down the arm. Also bumpy in a line from the injection site. 5/6/09 1 AM shaking & chills (did not take temperature) 5/6/09 330 AM shaking & chills gone 5/7/09 Decreased redness 5//09 prescribed CEPHALEXIN. Still monitoring.
Age: 68.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Tremor
Clinical narrative: 5/4/09 ZOSTAVAX administered; pain at injection site 5/5/09 redness/hardness 3 inches wide & 6 inches long extending from injection site & down the arm. Also bumpy in a line from the injection site. 5/6/09 1 AM shaking & chills (did not take temperature) 5/6/09 330 AM shaking & chills gone 5/7/09 Decreased redness 5//09 prescribed CEPHALEXIN. Still monitoring.
Age: 68.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Chills, Injection site discolouration, Injection site erythema, Injection site induration, Injection site pain
Clinical narrative: 5/4/09 ZOSTAVAX administered; pain at injection site 5/5/09 redness/hardness 3 inches wide & 6 inches long extending from injection site & down the arm. Also bumpy in a line from the injection site. 5/6/09 1 AM shaking & chills (did not take temperature) 5/6/09 330 AM shaking & chills gone 5/7/09 Decreased redness 5//09 prescribed CEPHALEXIN. Still monitoring.
Age: 68.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site pruritus, Pyrexia, Tremor
Clinical narrative: 5/4/09 ZOSTAVAX administered; pain at injection site 5/5/09 redness/hardness 3 inches wide & 6 inches long extending from injection site & down the arm. Also bumpy in a line from the injection site. 5/6/09 1 AM shaking & chills (did not take temperature) 5/6/09 330 AM shaking & chills gone 5/7/09 Decreased redness 5//09 prescribed CEPHALEXIN. Still monitoring.
Age: 35.0
Sex: M
Vaccine: FLU3, HEP
Symptoms: Unevaluable event
Clinical narrative: None stated
Age: 0.2
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC, RV1
Symptoms: Crying, Injection site erythema, Injection site swelling, Injection site warmth, Local reaction
Clinical narrative: Localized reaction with redness & swelling @ injection site, radiating heat.  check non-sotp crying > 3 hours (or more) post injection.
Age: 5.0
Sex: U
Vaccine: VARCEL
Clinical narrative: Patient presented shortly after receiving the vaccine with slight red rash to all body parts. Benadryl Administered.
Age: 5.0
Sex: F
Vaccine: HEPA
Symptoms: Dizziness, Dry skin, Fall, Heart rate normal, Loss of consciousness
Clinical narrative: Pt received #2 Hep A vaccine.  3 min. later became dizzy & fell.  ? loss of consciousness x few seconds.  BP- 80/60 Pulse- regular.  Skin warm/dry.  Child fine after going home + next day with symptoms.
Age: 5.0
Sex: F
Vaccine: HEPA
Symptoms: Skin warm
Clinical narrative: Pt received #2 Hep A vaccine.  3 min. later became dizzy & fell.  ? loss of consciousness x few seconds.  BP- 80/60 Pulse- regular.  Skin warm/dry.  Child fine after going home + next day with symptoms.
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, PNC, VARCEL
Symptoms: Decreased appetite, Fluid intake reduced, Irritability, Pyrexia, Rash generalised
Clinical narrative: Evening of 5-8-09.  Mom noticed a rash on child.  Child has had low grade fever.  Decreased appetite and fluid intake.  Fussy more than usual.  Pin head rash under eyes.  Sandpaper rash on torso, arms, legs (very few), & face
Age: 19.0
Sex: M
Vaccine: ANTH, TYP
Symptoms: Injection site papule, Injection site vesicles
Clinical narrative: Over 3 day weekend, use bandages slides off. Reaction occurs progressively starting around original vaccination point to upper arm. Exam reveals clustered vesicles/papules covering deltoid, spreading towards next.
Age: 29.0
Sex: F
Vaccine: ANTH
Symptoms: Drug exposure during pregnancy
Clinical narrative: THIS IS A FOLLOW-UP TO A PREVIOUSLY SUBMITTED VAERS REPORT 327376-1 (The previous report was not filed by this filer)  No additional notes on patient regarding site where vaccination received after Oct 2008 - assume resolved.  Records show delivery of male infant on 5 May 2009.  Notation of LGA and elevated billrubin, but otherwise appears healthy.
Age: 12.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Pulmonary embolism
Clinical narrative: Information has been received from a Registered Nurse (R.N) who heard that a 12 year old female patient, who on an unspecified date was vaccinated with a dose of GARDASIL. It was reported that the patient died on an unspecified date after receiving the vaccine. It was noted that the death occurred over one year ago. Attempts are being made to verify the existence of an identifiable patient. Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Autopsy, Cardiac arrest, Cardiomegaly, Cough, Death
Clinical narrative: Information has been received from a Registered Nurse (R.N) who heard that a 12 year old female patient, who on an unspecified date was vaccinated with a dose of GARDASIL. It was reported that the patient died on an unspecified date after receiving the vaccine. It was noted that the death occurred over one year ago. Attempts are being made to verify the existence of an identifiable patient. Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Pulmonary embolism, Respiratory tract congestion, White blood cell count increased
Clinical narrative: Information has been received from a Registered Nurse (R.N) who heard that a 12 year old female patient, who on an unspecified date was vaccinated with a dose of GARDASIL. It was reported that the patient died on an unspecified date after receiving the vaccine. It was noted that the death occurred over one year ago. Attempts are being made to verify the existence of an identifiable patient. Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Death
Clinical narrative: Information has been received from a Registered Nurse (R.N) who heard that a 12 year old female patient, who on an unspecified date was vaccinated with a dose of GARDASIL. It was reported that the patient died on an unspecified date after receiving the vaccine. It was noted that the death occurred over one year ago. Attempts are being made to verify the existence of an identifiable patient. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: HIBV, MMRV, PNC, HIBV, MMRV, PNC
Symptoms: Abnormal behaviour, Autism spectrum disorder, Convulsion, Discomfort, Disturbance in attention
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. On 18-APR-2007 a 12 month old male patient with a history of roseola and high fever 3 months before he was vaccinated with the first dose of PROQUAD (lot # 656890/0152U), site and route unknown. Concomitant therapy administered on 18-APR-2007 included a third dose of PEDVAXHIB (lot # 654398/078F) and fourth dose of PREVENAR (lot # B0362586). It was reported that the patient developed fever, rash and discomfort immediately after being vaccinated. Within 2 weeks his behavior changed dramatically, his language skills regressed, developed frequent fevers, experienced seizures and loss of eye contact. The patient's medical records from 05-FEB-2007 to October 2008 received from his primary care physician on 04-MAR-2009 indicated that he was seen on 19-OCT-2007 with parental concerns related to his speech development. In addition no real progress since age 1 was found and he did not respond to name when called. More concerns with behaviour were reported on 29-NOV-2007 along with frequent fevers. Episodes of stiffening and unresponsiveness and waking screaming were reported. In December 2007 was diagnosed with autism spectrum disorder. Laboratory tests performed on unspecified dates included "encephalitis", "autism" and "roseola". No further information is available. The original reporting source was not provided. The VAERS ID # is 340268. A standard lot check investigation was performed on 656890/0152U. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Standard lot check investigations were performed on lot # 654398/0784F. All in-process quality checks for the lot number in question were satisfactory. In addition, expanded lot check investigations were performed. The testing performed on the batches prior to release met all release specifications. The lots met the requirements of the Center for Biologics Evaluation and Research and were released. No further information is available.
Age: 1.0
Sex: M
Vaccine: HIBV, MMRV, PNC, HIBV, MMRV, PNC
Symptoms: Encephalitis, Immediate post-injection reaction, Pyrexia, Rash, Speech disorder developmental
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. On 18-APR-2007 a 12 month old male patient with a history of roseola and high fever 3 months before he was vaccinated with the first dose of PROQUAD (lot # 656890/0152U), site and route unknown. Concomitant therapy administered on 18-APR-2007 included a third dose of PEDVAXHIB (lot # 654398/078F) and fourth dose of PREVENAR (lot # B0362586). It was reported that the patient developed fever, rash and discomfort immediately after being vaccinated. Within 2 weeks his behavior changed dramatically, his language skills regressed, developed frequent fevers, experienced seizures and loss of eye contact. The patient's medical records from 05-FEB-2007 to October 2008 received from his primary care physician on 04-MAR-2009 indicated that he was seen on 19-OCT-2007 with parental concerns related to his speech development. In addition no real progress since age 1 was found and he did not respond to name when called. More concerns with behaviour were reported on 29-NOV-2007 along with frequent fevers. Episodes of stiffening and unresponsiveness and waking screaming were reported. In December 2007 was diagnosed with autism spectrum disorder. Laboratory tests performed on unspecified dates included "encephalitis", "autism" and "roseola". No further information is available. The original reporting source was not provided. The VAERS ID # is 340268. A standard lot check investigation was performed on 656890/0152U. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Standard lot check investigations were performed on lot # 654398/0784F. All in-process quality checks for the lot number in question were satisfactory. In addition, expanded lot check investigations were performed. The testing performed on the batches prior to release met all release specifications. The lots met the requirements of the Center for Biologics Evaluation and Research and were released. No further information is available.
Age: 1.0
Sex: M
Vaccine: HIBV, MMRV, PNC, HIBV, MMRV, PNC
Symptoms: Abnormal behaviour, Autism spectrum disorder, Childhood disintegrative disorder, Convulsion, Discomfort
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. On 18-APR-2007 a 12 month old male patient with a history of roseola and high fever 3 months before he was vaccinated with the first dose of PROQUAD (lot # 656890/0152U), site and route unknown. Concomitant therapy administered on 18-APR-2007 included a third dose of PEDVAXHIB (lot # 654398/078F) and fourth dose of PREVENAR (lot # B0362586). It was reported that the patient developed fever, rash and discomfort immediately after being vaccinated. Within 2 weeks his behavior changed dramatically, his language skills regressed, developed frequent fevers, experienced seizures and loss of eye contact. The patient's medical records from 05-FEB-2007 to October 2008 received from his primary care physician on 04-MAR-2009 indicated that he was seen on 19-OCT-2007 with parental concerns related to his speech development. In addition no real progress since age 1 was found and he did not respond to name when called. More concerns with behaviour were reported on 29-NOV-2007 along with frequent fevers. Episodes of stiffening and unresponsiveness and waking screaming were reported. In December 2007 was diagnosed with autism spectrum disorder. Laboratory tests performed on unspecified dates included "encephalitis", "autism" and "roseola". No further information is available. The original reporting source was not provided. The VAERS ID # is 340268. A standard lot check investigation was performed on 656890/0152U. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Standard lot check investigations were performed on lot # 654398/0784F. All in-process quality checks for the lot number in question were satisfactory. In addition, expanded lot check investigations were performed. The testing performed on the batches prior to release met all release specifications. The lots met the requirements of the Center for Biologics Evaluation and Research and were released. No further information is available.
Age: 1.0
Sex: M
Vaccine: HIBV, MMRV, PNC, HIBV, MMRV, PNC
Symptoms: Disturbance in attention, Immediate post-injection reaction, Laboratory test, Musculoskeletal stiffness, Pyrexia
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. On 18-APR-2007 a 12 month old male patient with a history of roseola and high fever 3 months before he was vaccinated with the first dose of PROQUAD (lot # 656890/0152U), site and route unknown. Concomitant therapy administered on 18-APR-2007 included a third dose of PEDVAXHIB (lot # 654398/078F) and fourth dose of PREVENAR (lot # B0362586). It was reported that the patient developed fever, rash and discomfort immediately after being vaccinated. Within 2 weeks his behavior changed dramatically, his language skills regressed, developed frequent fevers, experienced seizures and loss of eye contact. The patient's medical records from 05-FEB-2007 to October 2008 received from his primary care physician on 04-MAR-2009 indicated that he was seen on 19-OCT-2007 with parental concerns related to his speech development. In addition no real progress since age 1 was found and he did not respond to name when called. More concerns with behaviour were reported on 29-NOV-2007 along with frequent fevers. Episodes of stiffening and unresponsiveness and waking screaming were reported. In December 2007 was diagnosed with autism spectrum disorder. Laboratory tests performed on unspecified dates included "encephalitis", "autism" and "roseola". No further information is available. The original reporting source was not provided. The VAERS ID # is 340268. A standard lot check investigation was performed on 656890/0152U. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Standard lot check investigations were performed on lot # 654398/0784F. All in-process quality checks for the lot number in question were satisfactory. In addition, expanded lot check investigations were performed. The testing performed on the batches prior to release met all release specifications. The lots met the requirements of the Center for Biologics Evaluation and Research and were released. No further information is available.